6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Expensify and VAT IT Launch Integration Partnership to Simplify Global VAT Reclaim
Just now	United Maritime Reports Improved First Quarter 2026 Financial Results and Declares Quarterly Cash Dividend of $0.10 Per Share
1m ago	Data I/O to Present at the Planet MicroCap Investor Conference Powered by MicroCapClub
1m ago	Rapid7 Q1 2026 Threat Landscape Report Finds Vulnerability Exploitation Overtakes Social Engineering as the Top Initial Access Vector
1m ago	Jamal Satli Iglesias, Marriott International and Aimbridge Hospitality Announce Landmark All-Inclusive Resort in Riviera Maya

About

3.92USD+0.25 +6.81%

Closed • Updated at 13:36 GMT+00:00

Market Cap$645.28M

P/E Ratio6.56

Volume3.23M

Beta1.61

RSI49.12

Gross Margin99.49%

Health TechnologyPharmaceuticals: Major

Ironwood Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance

Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)

Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook

Community Chat

Ask AI